.png){kind=logo}
2021
Cancer immunology research
Conditional PD-1/PD-L1 probody therapeutics induce comparable antitumor immunity but reduced systemic toxicity compared with traditional anti–PD-1/PD-L1 agents
Details
Authors:
Olga Vasiljeva
Title of the Article:
Conditional PD-1/PD-L1 probody therapeutics induce comparable antitumor immunity but reduced systemic toxicity compared with traditional anti–PD-1/PD-L1 agents
Journal:
Cancer immunology research
Year of Publication:
2021
Pages:
str. 1451-1464
Volume and Issue Number:
vol. 9, no. 12
ISSN Number:
2326-6074
DOI (Digital Object Identifier):
10.1158/2326-6066.CIR-21-0031
Researchers
References
Access paper
Access the PDF publication document.
More documentation
Related publications
Browse all publications
